Hallmarks of triple negative breast cancer emerging at last?

被引：38

作者：

Bernardi, Rosa ^{[1
]}

Gianni, Luca ^{[2
]}

机构：

[1] Ist Sci San Raffaele, Div Mol Oncol, I-20132 Milan, Italy

[2] Hosp San Raffaele, Dept Med Oncol, I-20132 Milan, Italy

来源：

CELL RESEARCH | 2014年 / 24卷 / 08期

关键词：

D O I：

10.1038/cr.2014.61

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Triple negative breast cancers (TNBC) are clinically heterogeneous but mostly aggressive malignancies devoid of expression of the estrogen, progesterone and HER2 (ERBB2 or NEU) receptors. Recent evidence shows that basal endoplasmic reticulum stress (ERS) is typically activated in TNBC and cooperates with hypoxia signaling to promote tumor progression and relapse; ERS and hypoxia response may therefore be among the long-searched hallmarks of TNBC.

引用

页码：904 / 905

页数：2

共 50 条

[1] Hallmarks of triple negative breast cancer emerging at last?
Rosa Bernardi
Luca Gianni
Cell Research, 2014, 24 : 904 - 905
[2] Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A
Vanden Berghe, Wim
Szic, Katarzyna Szarc Vel
Declerck, Ken
Crans, Rene A. J.
Diddens, Jolien
Gerhauser, Clarissa
CANCER RESEARCH, 2016, 76
[3] Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A
Szic, Katarzyna Szarc Vel
Declerck, Ken
Crans, Rene A. J.
Diddens, Jolien
Scherf, David B.
Gerhaeuser, Clarissa
Berghe, Wim Vanden
ONCOTARGET, 2017, 8 (25) : 40434 - 40453
[4] HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer
Mansoori, Behzad
Terp, Mikkel Green
Mohammadi, Ali
Pedersen, Christina Bog
Ditzel, Henrik Jorn
Baradaran, Behzad
Gjerstorff, Morten Frier
CANCERS, 2021, 13 (20)
[5] Emerging therapies for triple-negative breast cancer
Anders, Carey K.
Carey, Lisa A.
BREAST CANCER MANAGEMENT, 2013, 2 (01) : 47 - 55
[6] Emerging treatment approaches for triple-negative breast cancer
Capuozzo, Maurizio
Celotto, Venere
Santorsola, Mariachiara
Fabozzi, Antonio
Landi, Loris
Ferrara, Francesco
Borzacchiello, Assunta
Granata, Vincenza
Sabbatino, Francesco
Savarese, Giovanni
Cascella, Marco
Perri, Francesco
Ottaiano, Alessandro
MEDICAL ONCOLOGY, 2023, 41 (01)
[7] Current and emerging biologic therapies for triple negative breast cancer
Shaikh, Saba S.
Emens, Leisha A.
EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (05) : 591 - 602
[8] Emerging Novel Therapeutics in Triple-Negative Breast Cancer
Lyons, Tomas G.
Traina, Tiffany A.
BREAST CANCER METASTASIS AND DRUG RESISTANCE: CHALLENGES AND PROGRESS, 2ND EDITION, 2019, 1152 : 377 - 399
[9] Emerging Therapeutics for Patients with Triple-Negative Breast Cancer
Elisa Agostinetto
Daniel Eiger
Kevin Punie
Evandro de Azambuja
Current Oncology Reports, 2021, 23
[10] Emerging targeted therapies in triple-negative breast cancer
Crown, J.
O'Shaughnessy, J.
Gullo, G.
ANNALS OF ONCOLOGY, 2012, 23 : 56 - 65

← 1 2 3 4 5 →